MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC RENAL FAILURE AND ASSESSMENT INFLUENCE DOSAGE OF ERYTROPOIETIN: 1 YEAR FOLLOW-UP

Abstract

Abstract is not available.

    Similar works